A Comprehensive Assessment of Quality of Antimalarial Medicines in Mainland Tanzania: Insights from Five Years of Postmarket Surveillance.

Autor: Mlugu EM; Department of Pharmaceutics and Pharmacy Practice, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mhagama J; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Matiko D; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Agustine S; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Nandonde M; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Masunga E; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Kunambi PP; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Sangeda RZ; Department of Pharmaceutical Microbiology, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mwalwisi YH; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania., Fimbo A; Tanzania Medicines and Medical Devices Authority, Dodoma, Tanzania.

Publikováno v: The American journal of tropical medicine and hygiene [Am J Trop Med Hyg] 2024 Oct 01. Date of Electronic Publication: 2024 Oct 01.

Efficacy of ivermectin and albendazole combination in suppressing transmission of lymphatic filariasis following mass administration in Tanzania: a prospective cohort study.

Autor: Fimbo AM; Department of Global Public Health, Karolinska Institutet at Karolinska University, Stockholm, Sweden.; Tanzania Medicines and Medical Devices Authority (TMDA), P. O, Box 77150, Dar Es Salaam, Tanzania., Mnkugwe RH; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, P. O, Box 65013, Dar Es Salaam, Tanzania., Mlugu EM; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P. O, Box 65013, Dar Es Salaam, Tanzania., Kunambi PP; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, P. O, Box 65013, Dar Es Salaam, Tanzania., Malishee A; National Institute for Medical Research, P. O. Box 9653, Dar Es Salaam, Tanzania., Minzi OMS; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P. O, Box 65013, Dar Es Salaam, Tanzania., Kamuhabwa AAR; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, P. O, Box 65013, Dar Es Salaam, Tanzania., Aklillu E; Department of Global Public Health, Karolinska Institutet at Karolinska University, Stockholm, Sweden. eleni.aklillu@ki.se.

Publikováno v: Infectious diseases of poverty [Infect Dis Poverty] 2024 Jun 12; Vol. 13 (1), pp. 44. Date of Electronic Publication: 2024 Jun 12.

Incidence and determinants of adverse events in individuals with HIV commencing Dolutegravir-based antiretroviral therapy in mainland Tanzania.

Autor: Fimbo A; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Mwalwisi YH; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Mwamwitwa K; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Matiko D; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Mfinanga E; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Lyimo J; World Health Organization, Dar Es Salaam, Tanzania., Sabasaba A; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Missago S; National Institute for Medical Research, Headquarters, Dar Es Salaam, Tanzania., Bukundi E; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Gotora G; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Respick D; Department of Epidemiology, School of Public Health, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Nkayamba A; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Masunga E; Tanzania Medicines and Medical Devices Authority (TMDA), Dodoma, Tanzania., Mnkugwe RH; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Kunambi PP; Department of Clinical Pharmacology, School of Biomedical Sciences, Campus College of Medicine, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Munishi C; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Musanhu CC; World Health Organization, Dar Es Salaam, Tanzania., Minzi OMS; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania., Mlugu EM; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar Es Salaam, Tanzania. mlugusonlove@gmail.com.

Publikováno v: Scientific reports [Sci Rep] 2024 Jan 05; Vol. 14 (1), pp. 615. Date of Electronic Publication: 2024 Jan 05.

Prevalence of urinary tract infection and antimicrobial resistance patterns of uropathogens with biofilm forming capacity among outpatients in morogoro, Tanzania: a cross-sectional study.

Autor: Mlugu EM; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania. mlugusonlove@gmail.com., Mohamedi JA; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Sangeda RZ; Department of Pharmaceutical Microbiology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania., Mwambete KD; Department of Pharmaceutical Microbiology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania.

Publikováno v: BMC infectious diseases [BMC Infect Dis] 2023 Oct 05; Vol. 23 (1), pp. 660. Date of Electronic Publication: 2023 Oct 05.

Pregnancy Increases CYP3A Enzymes Activity as Measured by the 4β-Hydroxycholesterol/Cholesterol Ratio.

Autor: Mlugu EM; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden.; Department of Pharmaceutics and Pharmacy Practice, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65013, Tanzania., Minzi OM; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65013, Tanzania., Kamuhabwa AAR; Department of Clinical Pharmacy and Pharmacology, School of Pharmacy, Muhimbili University of Health and Allied Sciences, Dar es Salaam P.O. Box 65013, Tanzania., Diczfalusy U; Division of Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, 14186 Stockholm, Sweden., Aklillu E; Division of Clinical Pharmacology, Department of Laboratory Medicine, Karolinska Institutet at Karolinska University Hospital, Huddinge, 14186 Stockholm, Sweden.

Publikováno v: International journal of molecular sciences [Int J Mol Sci] 2022 Dec 02; Vol. 23 (23). Date of Electronic Publication: 2022 Dec 02.